From CARE
Capital First announced that Credit Analysis & Research Limited (CARE) has assigned ratings to the instruments for an enhanced limit as given below -Non Convertible Debentures Rs 1550 crore (enhanced from Rs 1050 crore) - CARE AA+ (reaffirmed)
Subordinated Debt Issue Rs 400 crore (enhanced from Rs 200 crore) - CARE AA+ (reaffirmed)
Commercial Paper / Short Term Debt Programme Rs 1700 crore (enhanced from Rs 1200 crore) - CARE A1+ (reaffirmed)
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app